October 12, 2020

13 Oct 20 | BR | Celltrion | Korea Biomedical Review reports Celltrion has signed a contract to provide Herzuma® (biosimilar trastuzumab) and Truxima® (biosimilar rituximab) to the Brazilian Federal Government. Celltrion has also signed a contract to provide Truxi...

Please reload

Biosimilars bulletin 

October 4, 2020

Please reload

Search by tags